ClinConnect ClinConnect Logo
Search / Trial NCT06317233

Outcomes of a Multidisciplinary Program for the Treatment of Chronic Pelvic Pain

Launched by MEDSTAR HEALTH RESEARCH INSTITUTE · Mar 11, 2024

Trial Information

Current as of July 27, 2025

Enrolling by invitation

Keywords

Treatment Guide Patient Satisfaction Pain Scores

ClinConnect Summary

Chronic pelvic pain (CPP) is a common and multi-factorial condition resulting in high physical, emotional and psychological burden for patients. Multimodal treatments have been shown to be most effective in addressing the multifactorial nature of CPP, but remain challenging for patients and providers to navigate. Investigators have created a CPP treatment guide which clearly defines resources and management strategies in an effort to help patients understand their own diagnosis, treatment options and follow up schedule. The treatment guide includes mobile and web-based resources and applica...

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Women age 18 or older
  • Diagnosis of chronic pelvic pain
  • Exclusion Criteria:
  • Primary language other than English
  • Pregnancy
  • Inability to attend follow-up appointment

About Medstar Health Research Institute

MedStar Health Research Institute (MHRI) is a leading clinical research organization affiliated with MedStar Health, dedicated to advancing medical knowledge and improving patient care through innovative research initiatives. With a robust portfolio of clinical trials across various therapeutic areas, MHRI collaborates with healthcare professionals, academic institutions, and industry partners to facilitate the development of new treatments and interventions. The institute is committed to maintaining the highest standards of ethical conduct and scientific rigor while fostering a culture of inquiry that enhances the health and well-being of the communities it serves.

Locations

Washington, District Of Columbia, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported